Medicinal composition of astragalus, salvia miltrorrhiza and oxymatrine, and its preparing method

A composition and matrine technology, applied in the field of medicine to achieve the effect of meeting clinical needs
CN1977889AInactive Publication Date: 2007-06-13海安江理工技术转移中心有限公司

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
海安江理工技术转移中心有限公司
Publication Date
2007-06-13
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The present invention discloses a new medicine composition for curing hepatic diseases and its preparation method. It is formed from (by weight portion) 400-10000 portions of astragalus root, 200-6000 portions of salvia root and 10-200 portions of kurarinone, and also can be made up by using 2-200 portions of astragalus total saponin or astragalus polysaccharide, 2-200 portions of salvia total phenolic acid and 10-200 portions of kurarinone. Said medicine composition can be made into various dosage forms of oral preparation, injection and others. Said medicine composition can be used for curing diseases of viral hepatitis, medicamentous liver lesion, fatty liver and alcoholic hepatitis, etc.
Need to check novelty before this filing date? Find Prior Art

Description

1. Technical field

[0001] The invention belongs to the technical field of medicine, and relates to a pharmaceutical composition mainly made of astragalus or its extract, salvia miltiorrhiza or its extract and matrine, and a preparation method thereof. 2. Background technology

[0002] Hepatitis is a common and frequently-occurring disease. According to incomplete statistics, hepatitis patients and virus carriers account for 10% of the total population in my country. Among them, viral hepatitis is the main one, and viral hepatitis can be divided into: acute hepatitis, chronic hepatitis, severe hepatitis and biliary hepatitis. Hepatitis is a kind of infectious disease, because of its widespread prevalence, great harm, and high incidence rate, it is one of the difficult diseases recognized both at home and abroad. China is a high prevalence area of ​​hepatitis B, more than 40% of people have been infected by hepatitis B virus (HBV), and more than 100 million people are chronic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More